Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus in Conjunction With EYLEA® (Aflibercept) Versus EYLEA® Alone for Exudative AMD

NCT02732899 is registered in ClinicalTrials.gov with Maturi, Raj K., M.D., P.C. as lead sponsor.

NCT NCT02732899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus in Conjunction With EYLEA® (Aflibercept) Versus EYLEA® Alone for Exudative AMD
Lead sponsor
Maturi, Raj K., M.D., P.C.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
April 4, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age related macular degeneration